17

Rudin D, Kiss A, Wetz RV, Sottile VM. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials. J Gastroenterol Hepatol 2007; 22(7):977-83. [More details]

16

Pourseidi B, Khorram-Manesh A. Triple non-invasive diagnostic test for exclusion of common bile ducts stones before laparoscopic cholecystectomy. World J Gastroenterol 2007; 13(43):5745-9. [More details]

15

Kitagawa M, Hayakawa T. Antiproteases in the Treatment of Acute Pancreatitis. JOP. J Pancreas (Online) 2007; 8(4 Suppl):518-525. [More details]

14

Kitagawa M, Hayakawa T. Antiproteases and the Pancreas: Basic and Clinical Update. Conclusion Remarks. JOP. J Pancreas (Online) 2007; 8(4 Suppl):538-544. [More details]

13

Parlak E, Cicek B, Disibeyaz S, Kuran S, Sahin B. Early decision for precut sphincterotomy: Is it a risky preference?. Dig Dis Sci 2007; 52(3):845-51. [More details]

12

Pallotta OJ, Saccone GT, Woolford RE. Bio-sensor system discriminating between the biliary and pancreatic ductal systems. Med Biol Eng Comput 2006 ; 44(3):250-5. [More details]

11

Kruse A. Stenting the pancreatic duct. Scand J Gastroentero 2006; 41(6):633-5. [More details]

10

Bhatia V, Garg PK, Tandon RK, Madan K. Endoscopic retrograde cholangiopancreatography-induced acute pancreatitis often has a benign outcome. J Clin Gastroenterol 2006; 40(8):726-31. [More details]

9

Thomopoulos KC, Pagoni NA, Vagenas KA, Margaritis VG, Theocharis GI, Nikolopoulou VN. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis. Gastrointest Endosc 2006; 64(5):726-31. [More details]

8

Pungpapong S, Kongkam P, Rerknimitr R, Kullavanijaya P. Experience on endoscopic retrograde cholangiopancreatography at tertiary referral center in Thailand: risks and complications. J Med Assoc Thai 2005; 88(2):238-46. [More details]

7

Wu SD, Zhang ZH, Kong J, Li YJ, Jin JZ, Wang W, et al. Effects of somatostatin analogues on human sphincter of Oddi pressure. Hepatobiliary Pancreat Dis Int 2005; 4(2):302-5. [More details]

6

Wu SD, Zhang ZH, Jin JZ, Kong J, Wang W, Li DY, et al. Effects of different drugs on the sphincter of Oddi motility: study with choledochoscope manometry. Zhonghua Yi Xue Za Zhi 2005; 85(27):1911-5. [More details]

5

Singh VP, Chari ST. Protease inhibitors in acute pancreatitis: Lessons from the bench and failed clinical trials. Gastroenterology 2005; 128(7):2172-4. [More details]

4

Poon RT. Reply to: Prevention of post-ERCP pancreatitis: are there any pearls for sale?. Gastroenterology 2004; 127(1):350. [More details]

3

Gottumukkala SR. Prevention of post-ERCP pancreatitis: are there any pearls for sale?. Gastroenterology 2004; 127(1):348-50. [More details]

2

De La Torre Prados MV, García Alcántara A, Franquelo Villalonga E, Carmona Ibáñez C, Soler García A, Fernandez García I. Sphincterotomy and endoscopic retrograde cholangiopancreatography in acute pancreatitis: Therapeutics and prophylaxis. Medicina Intensiva 2003; 27(6):417-25. [More details]

1

Freeman ML. Prevention of post-ERCP pancreatitis: Pharmacologic solution or patient selection and pancreatic stents?. Gastroenterology 2003; 124(7):1977-80. [More details]